RecruitingNCT06037967

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders


Sponsor

University Hospital, Toulouse

Enrollment

3,200 participants

Start Date

Feb 28, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to build up a clinico-biological bank of samples from patients suspected of or suffering from allergic diseases (including asthma) or mast cell diseases in order to support future research in the field of allergic diseases. The biobank will help to identify new prognostic, diagnostic and/or predictive biomarkers.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is building a collection of blood and tissue samples (a biobank) from patients with allergic conditions, asthma, or mast cell disorders to help researchers better understand these diseases and develop new treatments. **You may be eligible if...** - You have a positive allergy skin test or blood test (specific IgE), or are being evaluated for allergies - You have been diagnosed with mastocytosis (a condition where too many mast cells accumulate in the body) - You have mast cell activation syndrome - You have a rare inherited condition called familial hyper-alpha tryptasemia - You have asthma of any severity - You are enrolled in a social security scheme **You may NOT be eligible if...** - You do not meet any of the above criteria - You are unable to understand or consent to the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Laurent GUILLEMINAULT

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06037967


Related Trials